Found 6 matching trials
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma PHASE3 This is a multicenter, randomized, double-blinded, controlled Phase 3 trial...
Show More Status
Active Not Recruiting
Location
Exelixis Clinical Site #116
Learn More & Join Trial
Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma PHASE2 The primary purpose of this study is to compare the objective response rate...
Show More Location
San Francisco Oncology Associates
Learn More & Join Trial
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067) PHASE3 The purpose of this study is to show that Nivolumab and/or Nivolumab in com...
Show More Location
Local Institution - 0085
Learn More & Join Trial
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer PHASE3 The purpose of this study was to evaluate the efficacy and safety of the co...
Show More Location
Pacific Cancer Medical Center, Inc
Learn More & Join Trial
Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma PHASE3 The purpose of this study is to compare the clinical benefit, as measured b...
Show More Learn More & Join Trial
An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma PHASE3 The purpose of this study is to see if BMS-986205 combined with nivolumab, ...
Show More Location
Angeles Clinic and Research Institute
Learn More & Join Trial